Literature DB >> 10499922

Viral dynamics of acute HIV-1 infection.

S J Little1, A R McLean, C A Spina, D D Richman, D V Havlir.   

Abstract

Viral dynamics were intensively investigated in eight patients with acute HIV infection to define the earliest rates of change in plasma HIV RNA before and after the start of antiretroviral therapy. We report the first estimates of the basic reproductive number (R(0)), the number of cells infected by the progeny of an infected cell during its lifetime when target cells are not depleted. The mean initial viral doubling time was 10 h, and the peak of viremia occurred 21 d after reported HIV exposure. The spontaneous rate of decline (alpha) was highly variable among individuals. The phase 1 viral decay rate (delta(I) = 0.3/day) in subjects initiating potent antiretroviral therapy during acute HIV infection was similar to estimates from treated subjects with chronic HIV infection. The doubling time in two subjects who discontinued antiretroviral therapy was almost five times slower than during acute infection. The mean basic reproductive number (R(0)) of 19.3 during the logarithmic growth phase of primary HIV infection suggested that a vaccine or postexposure prophylaxis of at least 95% efficacy would be needed to extinguish productive viral infection in the absence of drug resistance or viral latency. These measurements provide a basis for comparison of vaccine and other strategies and support the validity of the simian immunodeficiency virus macaque model of acute HIV infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10499922      PMCID: PMC2195636          DOI: 10.1084/jem.190.6.841

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  34 in total

1.  HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment. Comet Study Group.

Authors:  A U Neumann; R Tubiana; V Calvez; C Robert; T S Li; H Agut; B Autran; C Katlama
Journal:  AIDS       Date:  1999-04-16       Impact factor: 4.177

2.  Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy.

Authors:  D Finzi; J Blankson; J D Siliciano; J B Margolick; K Chadwick; T Pierson; K Smith; J Lisziewicz; F Lori; C Flexner; T C Quinn; R E Chaisson; E Rosenberg; B Walker; S Gange; J Gallant; R F Siliciano
Journal:  Nat Med       Date:  1999-05       Impact factor: 53.440

3.  The analysis of equilibrium in malaria.

Authors:  G MACDONALD
Journal:  Trop Dis Bull       Date:  1952-09

4.  Cell-associated viral RNA expression during acute infection with HIV type 1.

Authors:  N L Riggs; S J Little; D D Richman; J C Guatelli
Journal:  AIDS Res Hum Retroviruses       Date:  1998-09-01       Impact factor: 2.205

5.  Rate of HIV-1 decline following antiretroviral therapy is related to viral load at baseline and drug regimen.

Authors:  D W Notermans; J Goudsmit; S A Danner; F de Wolf; A S Perelson; J Mittler
Journal:  AIDS       Date:  1998-08-20       Impact factor: 4.177

6.  Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression.

Authors:  S Y Kim; R Byrn; J Groopman; D Baltimore
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

7.  Acute AIDS retrovirus infection. Definition of a clinical illness associated with seroconversion.

Authors:  D A Cooper; J Gold; P Maclean; B Donovan; R Finlayson; T G Barnes; H M Michelmore; P Brooke; R Penny
Journal:  Lancet       Date:  1985-03-09       Impact factor: 79.321

8.  Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen.

Authors:  J S McDougal; A Mawle; S P Cort; J K Nicholson; G D Cross; J A Scheppler-Campbell; D Hicks; J Sligh
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

9.  Primary human T-lymphotropic virus type III infection.

Authors:  D D Ho; M G Sarngadharan; L Resnick; F Dimarzoveronese; T R Rota; M S Hirsch
Journal:  Ann Intern Med       Date:  1985-12       Impact factor: 25.391

10.  HIV-1 replication is controlled at the level of T cell activation and proviral integration.

Authors:  M Stevenson; T L Stanwick; M P Dempsey; C A Lamonica
Journal:  EMBO J       Date:  1990-05       Impact factor: 11.598

View more
  110 in total

1.  The challenge of immune control of immunodeficiency virus.

Authors:  D Richman
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

2.  Estimating relative fitness in viral competition experiments.

Authors:  A F Marée; W Keulen; C A Boucher; R J De Boer
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Simian-human immunodeficiency virus containing a human immunodeficiency virus type 1 subtype-E envelope gene: persistent infection, CD4(+) T-cell depletion, and mucosal membrane transmission in macaques.

Authors:  S Himathongkham; N S Halpin; J Li; M W Stout; C J Miller; P A Luciw
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

4.  Normal physiology and HIV pathophysiology of human T-cell dynamics.

Authors:  D D Richman
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

5.  Kinetics of virus-specific CD8+ T cells and the control of human immunodeficiency virus infection.

Authors:  Miles P Davenport; Ruy M Ribeiro; Alan S Perelson
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

6.  Roles of target cells and virus-specific cellular immunity in primary simian immunodeficiency virus infection.

Authors:  Roland R Regoes; Rustom Antia; David A Garber; Guido Silvestri; Mark B Feinberg; Silvija I Staprans
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

7.  High HIV-1 RNA Among Newly Diagnosed People in Botswana.

Authors:  Vladimir Novitsky; Melanie Prague; Sikhulile Moyo; Tendani Gaolathe; Mompati Mmalane; Etienne Kadima Yankinda; Unoda Chakalisa; Refeletswe Lebelonyane; Nealia Khan; Kathleen M Powis; Erik Widenfelt; Simani Gaseitsiwe; Scott L Dryden-Peterson; Molly Pretorius Holme; Victor De Gruttola; Pam Bachanas; Joseph Makhema; Shahin Lockman; M Essex
Journal:  AIDS Res Hum Retroviruses       Date:  2018-01-17       Impact factor: 2.205

8.  Rapid evolution of the neutralizing antibody response to HIV type 1 infection.

Authors:  Douglas D Richman; Terri Wrin; Susan J Little; Christos J Petropoulos
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-18       Impact factor: 11.205

9.  Contribution of HIV-1 genomes that do not integrate to the basic reproductive ratio of the virus.

Authors:  John Wei Lau; David N Levy; Dominik Wodarz
Journal:  J Theor Biol       Date:  2014-12-12       Impact factor: 2.691

Review 10.  The role of antigenic stimulation and cytotoxic T cell activity in regulating the long-term immunopathogenesis of HIV: mechanisms and clinical implications.

Authors:  C Fraser; N M Ferguson; F de Wolf; R M Anderson
Journal:  Proc Biol Sci       Date:  2001-10-22       Impact factor: 5.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.